1. Home
  2. AHCO vs DAWN Comparison

AHCO vs DAWN Comparison

Compare AHCO & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.10

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$11.50

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
DAWN
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AHCO
DAWN
Price
$10.10
$11.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$13.60
$27.56
AVG Volume (30 Days)
852.0K
2.9M
Earning Date
02-24-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$3,255,213,000.00
$133,672,000.00
Revenue This Year
$1.07
$17.88
Revenue Next Year
$6.49
$52.38
P/E Ratio
$18.35
N/A
Revenue Growth
N/A
31.11
52 Week Low
$7.11
$5.64
52 Week High
$11.63
$13.20

Technical Indicators

Market Signals
Indicator
AHCO
DAWN
Relative Strength Index (RSI) 48.69 57.05
Support Level $9.46 $11.60
Resistance Level $10.87 $12.50
Average True Range (ATR) 0.36 0.99
MACD -0.07 -0.05
Stochastic Oscillator 43.49 49.40

Price Performance

Historical Comparison
AHCO
DAWN

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: